ARCHIVES

IDMC Halts Mekinist-Tafinlar Trial Early Due to OS Benefit; Recommends Crossover

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Herceptin With Adjuvant Chemo Improves Disease-Free Survival, Phase III Trial Finds

January 29, 2010

NCI Programs: Seven Win Awards For Cancer Genetics Network, Informatics

July 31, 1998

In Appropriations Hearings, Groups Seek NCI Bypass Budget, Differ On CDC Funding.

April 7, 2000

NI Communications Effort, Saves By Congress, Now A Major National Cancer Program Resource

August 15, 1975

Nurse Oncology Society Growing, developing Care Guidelines

August 19, 1977

Duke Picks Lyerly To Direct Cancer Center

May 2, 2003